Results

Total Results: 1,494 records

Showing results for "harms".

161. A Systematic Review of Postpartum Home Blood Pressure Monitoring, Postpartum Treatment of Hypertensive Disorders of Pregnancy, and Peripartum Magnesium Sulfate Regimens for Preeclampsia With Severe Features (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol-amendment.pdf
     April 20, 2022 - KQ 2: What are the effectiveness, comparative effectiveness, and harms of pharmacological treatments … Are there harms associated with the concomitant use of particular antihypertensive medications during … ) ● Other Harms o Generation or exacerbation of health disparities* o Anxiety associated with use … ) ● Harms o Severe adverse events* (e.g., electrolyte abnormalities, severe hypotension) o Infant … We expect to primarily rely on reported within-study differences in effects (or harms).

162. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol.pdf
     January 31, 2023 - We added age-inappropriate temper outburst to behavioral outcomes and fatigue to harms outcomes. … What are the harms associated with treating children under 18 years of age for disruptive behaviors … Do interventions for disruptive behaviors vary in effectiveness and harms based on treatment history … We will consider NRSIs for harms when the study is designed specifically to assess harms. … our experience that few trials of psychosocial interventions report harms.

163. The series of articles beginning with this issue of the Journal form the most up-to-date version of the Guide for Conducting Comparative Effectiveness Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-principles_methods.pdf
     August 01, 2009 - Reviews are systematic reviews of existing research on the effectiveness, comparative effectiveness, and harms … Balance of Benefits and Harms CERs aim to present benefits and harms for different treatments and tests … The decisionmakers, not the reviewers, must weigh the benefits, harms, and costs of the alternatives … • Assessing harms. • Assessing the quality of studies. • Finding evidence. … Challenges in systematic reviews that assess treatment harms [review].

164. Ptsd-Adults-Trauma-Interventions Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adults-trauma-interventions_executive.pdf
     April 01, 2013 - Scope and Key Questions This review compares the efficacy, effectiveness, and harms of psychological … KQ 3: For adults exposed to psychological trauma, how does efficacy, effectiveness, or harms of early … KQ 4: For adults exposed to psychological trauma, what are the absolute and comparative risks of harms … For assessment of the risk of harms, we also included retrospective controlled cohort studies. … effectiveness or risk of harms.

165. Depression-Treatment-Ssri Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_executive.pdf
     April 01, 2012 - How do the harms compare across different interventions? Key Question 3. … This trial had low risk of bias, and harms were well monitored and reported. … How do the harms compare across different interventions? … The reporting and collecting of harms was problematic, particularly for predefining harms, including … Better reporting of harms in randomized trials: An extension of the CONSORT statement.

166. Ear-Infection Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_executive.pdf
     May 01, 2013 - Harms or Tolerability Six of the treatment comparisons included in the review reported on harms. … Evidence was insufficient for other harms. … Low for harms of TT TT plus adenoidectomy vs. … Moderate for harms of TT Adenoidectomy vs. … Low for no difference 15 safety and harms.

167. Despite steadily increasing health care expenditures in the United States, improved health outcomes and quality remain elusive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-interventions-comparing_methods.pdf
     November 01, 2008 - Reviews are systematic reviews of existing research on the effectiveness, comparative effectiveness, and harms … broad variety of reviews that assess the effectiveness, comparative effectiveness, and comparative harms … The aim of a Comparative Effectiveness Review is to depict how the relative benefits and harms of a … Evidence on harms is often hard to determine from tightly controlled randomized trials. … Attempts to explore subgroups for which benefits or harms of specific interventions vary may be needed

168. Despite steadily increasing health care expenditures in the United States, improved health outcomes and quality remain elusive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_slutsky_comparing_medical_interventions.pdf
     November 01, 2008 - Reviews are systematic reviews of existing research on the effectiveness, comparative effectiveness, and harms … broad variety of reviews that assess the effectiveness, comparative effectiveness, and comparative harms … The aim of a Comparative Effectiveness Review is to depict how the relative benefits and harms of a … Evidence on harms is often hard to determine from tightly controlled randomized trials. … Attempts to explore subgroups for which benefits or harms of specific interventions vary may be needed

169. Chronic Urinary Retention: Comparative Effectiveness and Harms of Treatments | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/chronic-urinary-retention/research

170. Executive summary_Comparative Effectiveness Review No. 276: Diagnosis and Management of Obsessive Compulsive Disorders in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-276-ocd-executive-summary.pdf
     December 01, 2024 - KQ 2: What are the comparative effects and harms of treatment interventions, used alone or in combination … KQ 2.a: How do the effectiveness and harms vary with patient, family, social, or other characteristics … Harms: The side effects of SSRIs and clomipramine were inconsistently reported, precluding graded conclusions … No study collected or reported potential harms of behavioral interventions. … No study collected or reported potential harms of behavioral interventions.

171. Whole-Body Vibration Therapy for Osteoporosis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
     January 01, 2020 - Reviewed studies offered little information on potential harms. … What primary and secondary outcomes and harms were examined? e. … What comparators were used to examine benefits and harms? f. … Only two studies reported minor harms from the vibration intervention.52,71 It was not clear that harms … Harms have been minimally reported and it is not clear whether harms information was systematically

172. Stem-Cell-Children Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_surveillance.pdf
     October 29, 2012 - For pediatric patients with malignant solid tumors, what are the comparative harms of HSCT and conventional … For pediatric patients with inherited metabolic diseases, what are the comparative harms of HSCT, ERT … Key question 6: For pediatric patients with autoimmune diseases, what are the comparative harms of HSCT … Key question # 2: For pediatric patients with malignant solid tumors, what are the comparative harms … Key question # 6: For pediatric patients with autoimmune diseases, what are the comparative harms of

173. Noninvasive Treatments for Low Back Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_research_executive.pdf
     February 01, 2016 - serious harms. … When reported, harms were typically related to muscle soreness and increased pain, or no harms were … and no harms were reported. … and no harms were reported. … and no harms were reported.

174. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
     March 01, 2012 - Summary of Evidence on Comparative Long-Term Benefits and Harms of ACEIs, ARBs, and DRIs in Patients … Summary of evidence on comparative long-term benefits and harms of ACEIs, ARBs, and DRIs in patients … Summary of Evidence on Comparative Long-Term Benefits and Harms of ACEIs, ARBs, and DRIs in patients … Summary of Evidence on Comparative Long-Term Benefits and Harms of ACEIs, ARBs, and DRIs in patients … Summary of Evidence on Comparative Long-Term Benefits and Harms of ACEIs, ARBs, and DRIs in patients

175. Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-fatigue_executive.pdf
     July 01, 2016 - (c) What harms are associated with diagnosing ME/CFS? Key Question 2. … What are the (a) benefits and (b) harms of therapeutic interventions for patients with ME/CFS, and … Studies of potential harms from diagnosis were also included, such as psychological harms, labeling … What harms are associated with diagnosing ME/CFS? … Harms were not reported in the studies. Table C.

176. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
     May 18, 2011 - Question 6: Harms What are the potential harms of fecal DNA testing? … Decreased Colorectal Cancer or All-Cause Mortality Colorectal Cancer Treatment Screening Harms … Draft analytic framework the benefits and harms of Fecal DNA Testing in Screening for Colorectal Cancer … KQ 6: Any reported harms, including test inaccuracy (i.e., false-positive or false–negative results … The quality assessment of adverse effects and harms data will be informed by the methods guidance

177. Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
     July 01, 2017 - 16 (2,422)b A small but notable proportion of patients experienced harms. … Studies in which harms, if any, were reported were inconsistent. ��� N = number of subjects a All … Transfusion: RR 1.62 (1.07 to 2.46) ��� Harms 21 (3,746) Urological and nonurological complications … Transfusion: RR 0.75 (0.60 to 0.94) ��� Harms 32 (16,965) RCT: 1 Ret: 31 The RCT showed higher rates … Transfusion: RR 1.08 (0.63 to 1.87) ��� Harms 7 (2,000) Inconsistently reported.

178. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol-amendment.pdf
     March 22, 2023 - We added age- inappropriate temper outburst to behavioral outcomes and fatigue to harms outcomes. … What are the harms associated with treating children under 18 years of age for disruptive behaviors … Do interventions for disruptive behaviors vary in effectiveness and harms based on treatment history … We will consider NRSIs for harms when the study is designed specifically to assess harms. … our experience that few trials of psychosocial interventions report harms.

179. EHC Protocol: Making Healthcare Safer IV: Engaging Family Caregivers with Structured Communication for Safe Care Transitions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-protocol.pdf
     August 04, 2023 - What is the frequency and severity of harms associated with care transitions? 2. … What patient safety measures or indicators have been used to examine these harms? 3. … For this topic, we may need to consider a number of different PSPs that focus on the targeted harms … For this topic that focuses on preventing or mitigating harms associated with care transitions, we … We will also report unintended harms of this PSP as described in relevant studies.

180. Project Title: Evaluation of Suspicious Skin Lesions Using Non-Invasive Diagnostic Techniques, a Technical Brief (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
     August 23, 2010 - What are the potential safety issues and harms associated with the use of non-invasive diagnostic techniques … For potential harms with the relevant devices, we will query the FDA Manufacturer and User Facility … Device Experience (MAUDE) database for any reported harms with the use of the relevant devices. … have been delayed or not detected • Probability/prevalence of unnecessary biopsies • Reduction of harms … We will also record the outcomes being assessed in each study, including harms related to the particular